Table of Content
1 Hormonal Contraceptive Market Introduction and Overview
1.1 Hormonal Contraceptive Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Hormonal Contraceptive Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Hormonal Contraceptive Revenue and Market Share by Type
2.3 Global Hormonal Contraceptive Sales and Market Share by Type
3 Global Hormonal Contraceptive Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Hormonal Contraceptive Revenue Market Share by Application (2019-2024)
3.3 Global Hormonal Contraceptive Sales Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Hormonal Contraceptive Market Size (2019-2024)
4.2 Hormonal Contraceptive Growth Trends Analysis by Regions
4.2.1 Hormonal Contraceptive Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Hormonal Contraceptive Historic Revenue Market Size by Regions (2019-2024)
4.2.3 Hormonal Contraceptive Historic Sales Market Size by Regions (2019-2024)
4.2.4 North America Hormonal Contraceptive Market Size (2019-2024)
4.2.5 Europe Hormonal Contraceptive Market Size (2019-2024)
4.2.6 Asia-Pacific Hormonal Contraceptive Market Size (2019-2024)
4.2.7 Latin America Hormonal Contraceptive Market Size (2019-2024)
4.2.8 Middle East & Africa Hormonal Contraceptive Market Size (2019-2024)
5 North America
5.1 North America Hormonal Contraceptive Revenue by Countries
5.1.1 North America Hormonal Contraceptive Revenue by Countries (2019-2024)
5.1.2 North America Hormonal Contraceptive Sales by Countries (2019-2024)
5.2 North America Hormonal Contraceptive Sales by Types
5.3 North America Hormonal Contraceptive Sales by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Hormonal Contraceptive Revenue by Countries
6.1.1 Asia Pacific Hormonal Contraceptive Revenue by Countries (2019-2024)
6.1.2 Asia Pacific Hormonal Contraceptive Sales by Countries (2019-2024)
6.2 Asia Pacific Hormonal Contraceptive Sales by Types
6.3 Asia Pacific Hormonal Contraceptive Sales by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hormonal Contraceptive Revenue by Countries
7.1.1 Europe Hormonal Contraceptive Revenue by Countries (2019-2024)
7.1.2 Europe Hormonal Contraceptive Sales by Countries (2019-2024)
7.2 Europe Hormonal Contraceptive Sales by Types
7.3 Europe Hormonal Contraceptive Sales by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Hormonal Contraceptive Revenue by Countries
8.1.1 Latin America Hormonal Contraceptive Revenue by Countries (2019-2024)
8.1.2 Latin America Hormonal Contraceptive Sales by Countries (2019-2024)
8.2 Latin America Hormonal Contraceptive Sales by Types
8.3 Latin America Hormonal Contraceptive Sales by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Hormonal Contraceptive Revenue by Countries
9.1.1 Middle East & Africa Hormonal Contraceptive Revenue by Countries (2019-2024)
9.1.2 Middle East & Africa Hormonal Contraceptive Sales by Countries (2019-2024)
9.2 Middle East & Africa Hormonal Contraceptive Sales by Types
9.3 Middle East & Africa Hormonal Contraceptive Sales by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Hormonal Contraceptive Market Competition, by Players
10.1 Global Hormonal Contraceptive Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Hormonal Contraceptive Players Market Share in 2023
10.2.2 Top 6 Hormonal Contraceptive Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Hormonal Contraceptive Players Head Office, Business Provided
10.4 Hormonal Contraceptive Mergers & Acquisitions
10.5 Hormonal Contraceptive New Entrants and Expansion Plans
11 Players Profiles
11.1 Abbvie, Inc (U.S.)
11.1.1 Abbvie, Inc (U.S.) Company Profile
11.1.2 Hormonal Contraceptive Product Overview
11.1.3 Abbvie, Inc (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.1.4 Abbvie, Inc (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 Afaxys, Inc. (U.S.)
11.2.1 Afaxys, Inc. (U.S.) Company Profile
11.2.2 Hormonal Contraceptive Product Overview
11.2.3 Afaxys, Inc. (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.2.4 Afaxys, Inc. (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 Merck & Co Inc. (U.S.)
11.3.1 Merck & Co Inc. (U.S.) Company Profile
11.3.2 Hormonal Contraceptive Product Overview
11.3.3 Merck & Co Inc. (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.3.4 Merck & Co Inc. (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Teva Pharmaceuticals Industries Ltd. (Israel)
11.4.1 Teva Pharmaceuticals Industries Ltd. (Israel) Company Profile
11.4.2 Hormonal Contraceptive Product Overview
11.4.3 Teva Pharmaceuticals Industries Ltd. (Israel) Hormonal Contraceptive Market Performance (2019-2024)
11.4.4 Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bayer AG (Germany)
11.5.1 Bayer AG (Germany) Company Profile
11.5.2 Hormonal Contraceptive Product Overview
11.5.3 Bayer AG (Germany) Hormonal Contraceptive Market Performance (2019-2024)
11.5.4 Bayer AG (Germany) Business Overview
11.5.5 Recent Developments and Plans
11.6 Pfizer Inc. (U.S.)
11.6.1 Pfizer Inc. (U.S.) Company Profile
11.6.2 Hormonal Contraceptive Product Overview
11.6.3 Pfizer Inc. (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.6.4 Pfizer Inc. (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Agile Therapeutics (U.S.)
11.7.1 Agile Therapeutics (U.S.) Company Profile
11.7.2 Hormonal Contraceptive Product Overview
11.7.3 Agile Therapeutics (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.7.4 Agile Therapeutics (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 Cupid Ltd. (India)
11.8.1 Cupid Ltd. (India) Company Profile
11.8.2 Hormonal Contraceptive Product Overview
11.8.3 Cupid Ltd. (India) Hormonal Contraceptive Market Performance (2019-2024)
11.8.4 Cupid Ltd. (India) Business Overview
11.8.5 Recent Developments and Plans
11.9 Helm AG (Germany)
11.9.1 Helm AG (Germany) Company Profile
11.9.2 Hormonal Contraceptive Product Overview
11.9.3 Helm AG (Germany) Hormonal Contraceptive Market Performance (2019-2024)
11.9.4 Helm AG (Germany) Business Overview
11.9.5 Recent Developments and Plans
11.10 Church & Dwight Co., Inc (U.S.)
11.10.1 Church & Dwight Co., Inc (U.S.) Company Profile
11.10.2 Hormonal Contraceptive Product Overview
11.10.3 Church & Dwight Co., Inc (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.10.4 Church & Dwight Co., Inc (U.S.) Business Overview
11.10.5 Recent Developments and Plans
11.11 Organon group of companies (U.S.)
11.11.1 Organon group of companies (U.S.) Company Profile
11.11.2 Hormonal Contraceptive Product Overview
11.11.3 Organon group of companies (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.11.4 Organon group of companies (U.S.) Business Overview
11.11.5 Recent Developments and Plans
11.12 Reckitt Benckiser Group PLC (U.K.)
11.12.1 Reckitt Benckiser Group PLC (U.K.) Company Profile
11.12.2 Hormonal Contraceptive Product Overview
11.12.3 Reckitt Benckiser Group PLC (U.K.) Hormonal Contraceptive Market Performance (2019-2024)
11.12.4 Reckitt Benckiser Group PLC (U.K.) Business Overview
11.12.5 Recent Developments and Plans
11.13 Veru Inc. (U.S.)
11.13.1 Veru Inc. (U.S.) Company Profile
11.13.2 Hormonal Contraceptive Product Overview
11.13.3 Veru Inc. (U.S.) Hormonal Contraceptive Market Performance (2019-2024)
11.13.4 Veru Inc. (U.S.) Business Overview
11.13.5 Recent Developments and Plans
11.14 Boehringer Ingelheim International GmbH (Germany)
11.14.1 Boehringer Ingelheim International GmbH (Germany) Company Profile
11.14.2 Hormonal Contraceptive Product Overview
11.14.3 Boehringer Ingelheim International GmbH (Germany) Hormonal Contraceptive Market Performance (2019-2024)
11.14.4 Boehringer Ingelheim International GmbH (Germany) Business Overview
11.14.5 Recent Developments and Plans
11.15 Novartis AG (Switzerland)
11.15.1 Novartis AG (Switzerland) Company Profile
11.15.2 Hormonal Contraceptive Product Overview
11.15.3 Novartis AG (Switzerland) Hormonal Contraceptive Market Performance (2019-2024)
11.15.4 Novartis AG (Switzerland) Business Overview
11.15.5 Recent Developments and Plans
11.16 Lupin (India)
11.16.1 Lupin (India) Company Profile
11.16.2 Hormonal Contraceptive Product Overview
11.16.3 Lupin (India) Hormonal Contraceptive Market Performance (2019-2024)
11.16.4 Lupin (India) Business Overview
11.16.5 Recent Developments and Plans
11.17 Glenmark Pharmaceuticals (India)
11.17.1 Glenmark Pharmaceuticals (India) Company Profile
11.17.2 Hormonal Contraceptive Product Overview
11.17.3 Glenmark Pharmaceuticals (India) Hormonal Contraceptive Market Performance (2019-2024)
11.17.4 Glenmark Pharmaceuticals (India) Business Overview
11.17.5 Recent Developments and Plans
12 Global Hormonal Contraceptive Forecast Market Analysis by Type
12.1 Global Hormonal Contraceptive Revenue Market Forecast by Type (2024-2030)
12.2 Global Hormonal Contraceptive Sales Market Forecast by Type (2024-2030)
13 Global Hormonal Contraceptive Forecast Market Analysis by Application
13.1 Hormonal Contraceptive Revenue Market Forecast by Application (2024-2030)
13.2 Hormonal Contraceptive Sales Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Hormonal Contraceptive Forecast Market Size (2024-2030)
14.2 Hormonal Contraceptive Growth Trends Forecast Analysis by Regions
14.2.1 Hormonal Contraceptive Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 Hormonal Contraceptive Sales Forecast Market Size by Regions (2024-2030)
14.2.3 North America Hormonal Contraceptive Forecast Market Size (2024-2030)
14.2.4 Europe Hormonal Contraceptive Forecast Market Size (2024-2030)
14.2.5 Asia-Pacific Hormonal Contraceptive Forecast Market Size (2024-2030)
14.2.6 Latin America Hormonal Contraceptive Forecast Market Size (2024-2030)
14.2.7 Middle East & Africa Hormonal Contraceptive Forecast Market Size (2024-2030)
15 Hormonal Contraceptive Manufacturing Cost Analysis
15.1 Hormonal Contraceptive Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Hormonal Contraceptive
15.4 Hormonal Contraceptive Industrial Chain Analysis
16 Market Channel, Distributors, Traders and Dealers
16.1 Market Channel Status
16.1.1 Direct Marketing
16.1.2 Indirect Marketing
16.2 Hormonal Contraceptive Typical Distributors
16.3 Hormonal Contraceptive Typical Customers
17 Hormonal Contraceptive Industry Dynamic Analysis
17.1 Hormonal Contraceptive Market Trends Analysis
17.2 Hormonal Contraceptive Market Drivers Analysis
17.3 Hormonal Contraceptive Market Challenges Analysis
17.4 Hormonal Contraceptive Market Restraints Analysis
18 Research Findings and Conclusion
